Groupama Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$137M Buy
111,684
+16,308
+17% +$16.7M 1.72% 16
2026
Q1
$87.7M Sell
95,376
-2,180
-2% -$2.21M 1.28% 22
2025
Q4
$105M Buy
97,556
+8,333
+9% +$7.97M 1.53% 16
2025
Q3
$68.1M Sell
89,223
-15,395
-15% -$11.5M 1% 26
2025
Q2
$81.1M Buy
104,618
+3,396
+3% +$2.64M 1.34% 18
2025
Q1
$83.3M Buy
101,222
+9,384
+10% +$7.81M 1.66% 15
2024
Q4
$71.1M Buy
91,838
+3,373
+4% +$2.79M 1.45% 17
2024
Q3
$62.9M Buy
88,465
+458
+0.5% +$412K 1.63% 16
2024
Q2
$79.7M Buy
88,007
+6,975
+9% +$5.58M 1.08% 21
2024
Q1
$71.8M Sell
81,032
-16,372
-17% -$11.7M 1.31% 19
2023
Q4
$56.8M Buy
+97,404
New +$56.9M 1.48% 16

Other funds holding LLY

Groupama Asset Management's LLY Position: Q2 2026 in Review

Groupama Asset Management increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $16.7M and bringing the position to 111,684 shares worth $137M. The position accounts for 1.72% of the portfolio, ranked #16.

Groupama Asset Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Groupama Asset Management held 111,684 shares of Eli Lilly worth $137M as of Q2 2026.
  • Groupama Asset Management bought 16,308 Eli Lilly shares in Q2 2026, an estimated $16.7M.
  • Eli Lilly made up 1.72% of Groupama Asset Management's portfolio in Q2 2026, its #16 holding.
  • Groupama Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.